Table 1: Baseline Characteristics of Liver Fibrosis Progression Substudy Participants.
| LFP Substudy | |
|---|---|
| No. participants enrolled | 230 |
| Demographics | |
| Age (years; median, IQR) | 35 [28, 42] |
| Gender (N, % female) | 28 (12.2) |
| Race | |
| Black (N, %) | 14 (6.1) |
| Hispanic/Latino (N, %) | 16 (7.0) |
| Asian (N, %) | 76 (33.0) |
| White (N, %) | 120 (52.2) |
| Other (N, %) | 4 (1.7) |
| Hepatitis Coinfection | |
| Hepatitis B1 (%) | 12 (5.4) |
| Hepatitis C2 (%) | 14 (6.1) |
| Laboratory Results | |
| CD4 (cells/μl; median, IQR) | 647 [583, 758] |
| Nadir CD4 (cells/ μl; median, IQR) | 554 [471, 654] |
| HIV RNA (log10copies/mL; median, IQR) | 4.4 [3.8, 4.8] |
| HIV RNA, undetectable (N, % with RNA ≤ 400 copies/mL) | 9 (3.9) |
| AST/SGOT (IU/L; median, IQR) | 24 [20, 31] |
| ALT/SGPT (IU/L; median, IQR) | 24 [18, 35] |
| Platelets (log10cells/mm3; median, IQR) | 5.4 [5.3, 5.4] |
1
Hepatitis B defined as HBsAg positive based on a test within one year before randomisation
2
Hepatitis C defined as HCV antibody positive from any time before randomisation